Results 11 to 20 of about 114,000 (325)

Acute Pericarditis and Cancer Risk: A Matched Cohort Study Using Linked UK Primary and Secondary Care Data [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background We aimed to examine whether acute pericarditis is an indicator of undetected cancer and identify patient‐level factors associated with high cancer risk among patients presenting with pericarditis. Methods and Results A population‐based matched
Kirstine Kobberøe Søgaard, Henrik Toft Sørensen, Liam Smeeth, Krishnan Bhaskaran   +3 more
doaj   +3 more sources

Myocarditis and Pericarditis After Vaccination for COVID-19.

Journal of the American Medical Association (JAMA), 2021
Methods | Forty hospitals in Washington, Oregon, Montana, and Los Angeles County, California, that were part of the Providence health care system and used the same electronic medical record (EMR) were included.
G. Diaz, Guilford T Parsons, Sara K Gering, Audrey Meier, I. Hutchinson, A. Robicsek   +5 more
semanticscholar   +2 more sources

COVID-19, Myocarditis and Pericarditis

Circulation Research, 2023
Viral infections are a leading cause of myocarditis and pericarditis worldwide, conditions that frequently coexist. Myocarditis and pericarditis were some of the early comorbidities associated with SARS-CoV-2 infection and COVID-19.
D. Fairweather, Danielle J Beetler, Damian N Di Florio, Nicolas Musigk, Bettina Heidecker, L. Cooper   +5 more
semanticscholar   +1 more source

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

Nature Medicine, 2021
Although myocarditis and pericarditis were not observed as adverse events in coronavirus disease 2019 (COVID-19) vaccine trials, there have been numerous reports of suspected cases following vaccination in the general population.
M. Patone, X. Mei, L. Handunnetthi, S. Dixon, F. Zaccardi, M. Shankar-Hari, P. Watkinson, K. Khunti, A. Harnden, C. Coupland, K. Channon, N. Mills, Aziz Sheikh, J. Hippisley-Cox   +13 more
semanticscholar   +1 more source

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis

BMJ Open, 2023
Objective To summarise the available evidence on the risk of myocarditis and/or pericarditis following mRNA COVID-19 vaccination, compared with the risk among unvaccinated individuals in the absence of COVID-19 infection.
Abdallah Alami, D. Krewski, N. Farhat, D. Mattison, K. Wilson, Christopher A Gravel, P. Farrell, J. Crispo, Nisrine Haddad, S. Pérez-Lloret, P. Villeneuve   +10 more
semanticscholar   +1 more source

Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England

PLoS Medicine, 2023
Background An increased risk of myocarditis or pericarditis after priming with mRNA Coronavirus Disease 2019 (COVID-19) vaccines has been shown but information on the risk post-booster is limited.
J. Stowe, Elizabeth Miller, N. Andrews, H. Whitaker   +3 more
semanticscholar   +1 more source

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada

JAMA Network Open, 2022
This cohort study estimates rates of myocarditis and pericarditis after receipt of an mRNA COVID-19 vaccine among individuals in Ontario, Canada, stratified by recipients’ age and sex and by the vaccine product, schedule, and interdose interval.
S. Buchan, C. Y. Seo, Caitlin Johnson, Sarah Alley, J. Kwong, S. Nasreen, A. Calzavara, Diane Lu, T. Harris, Kelly Yu, Sarah E. Wilson   +10 more
semanticscholar   +1 more source

Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review

British medical journal, 2022
Objectives To synthesise evidence on incidence rates and risk factors for myocarditis and pericarditis after use of mRNA vaccination against covid-19, clinical presentation, short term and longer term outcomes of cases, and proposed mechanisms.
J. Pillay, L. Gaudet, A. Wingert, L. Bialy, A. Mackie, D. Paterson, L. Hartling   +6 more
semanticscholar   +1 more source

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

Nature Communications, 2022
Cases of myocarditis and pericarditis have been reported following the receipt of Covid-19 mRNA vaccines. As vaccination campaigns are still to be extended, we aimed to provide a comprehensive assessment of the association, by vaccine and across sex and ...
S. Le Vu, M. Bertrand, Marie-Joëlle Jabagi, Jérémie Botton, J. Drouin, B. Baricault, Alain Weill, R. Dray-Spira, Mahmoud Zureik   +8 more
semanticscholar   +1 more source

Pediatric Pericarditis: Update

Current Cardiology Reports, 2023
Purpose of Review While there have now been a variety of large reviews on adult pericarditis, this detailed review specifically focuses on the epidemiology, clinical presentation, diagnosis, and management of pediatric pericarditis.
Rida Shahid, Justin B. Jin, K. Hope, H. Tunuguntla, S. Amdani   +4 more
semanticscholar   +1 more source